The Lowdown - An AI-based medical device that uniquely combines clinical guidance with real user experience to support improved contraceptive understanding and use.

The Lowdown - 一种基于人工智能的医疗设备，将临床指导与真实用户体验独特地结合起来，以支持提高避孕药具的理解和使用。

• 批准号: 10103064
• 金额: $ 48.36万
• 依托单位: GET THE LOWDOWN LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10103064
• 关键词: Lowdown; AI; based; medical; device

With the combined support of Innovate-UK and investment finance, Get The Lowdown Ltd (GTLD) will develop the first dedicated and clinically validated platform that combines the latest clinical guidance with real user experience to provide tailored contraceptive advice specific to the user across all forms of contraception and in doing so reducing the need for an appointment with a healthcare professional to address commonly asked questions. The concept has been designed to address key challenges in accessing support in this complex area of healthcare and known gaps in knowledge in Primary and Secondary Care with information given in an easy-to-understand format aimed at all target users regardless of ethnicity/culture, age, gender and level of health literacy. Combined grant and investor funding will accelerate development and exploitation in the global FemTech market, forecast to reach $5.0Bn by 2033 and support future application across wider health conditions including fertility, polycystic ovary syndrome and endometriosis.

在Innovate-UK和投资融资的联合支持下，Get the Lowdown Ltd （GTLD）将开发第一个专门的临床验证平台，该平台将最新的临床指导与真实的用户体验相结合，为所有避孕形式的用户提供量身定制的避孕建议，从而减少与医疗保健专业人员预约解决常见问题的需要。该概念旨在解决在这一复杂的保健领域获得支助方面的主要挑战，以及在初级和二级保健方面已知的知识差距，其信息以易于理解的形式提供，针对所有目标用户，无论其种族/文化、年龄、性别和卫生知识水平如何。联合拨款和投资者资金将加速全球FemTech市场的开发和利用，预计到2033年将达到50亿美元，并支持未来在更广泛的健康状况下的应用，包括生育、多囊卵巢综合征和子宫内膜异位症。